Omeros Corp. | Mutual Funds
Mutual Funds that own Omeros Corp.
Vanguard Total Stock Market Index Fund
1,158,369
2.38%
0
0%
07/31/2018
iShares Russell 2000 ETF
958,963
1.98%
-513
0.05%
09/06/2018
Vanguard Extended Market Index Fund
600,526
1.24%
801
0.02%
07/31/2018
iShares Nasdaq Biotechnology ETF
557,112
1.14%
-7,287
0.15%
09/06/2018
iShares Russell 2000 Growth ETF
439,197
0.9%
0
0.1%
09/06/2018
SPDR S&P Pharmaceuticals ETF
249,679
0.51%
0
1.57%
09/06/2018
iShares US Pharmaceuticals ETF
238,821
0.49%
0
1.31%
09/06/2018
Fidelity Spartan Extended Market Index Fund
204,830
0.42%
0
0.02%
07/31/2018
Schwab US Small Cap ETF
125,612
0.26%
0
0.04%
09/06/2018
iShares Micro Cap ETF
121,691
0.25%
0
0.28%
09/06/2018
| Address |
The Omeros Building
Seattle Washington 98119
United States
|
|
Employees
|
- |
| Website |
http://www.omeros.com |
| Updated |
07/08/2019 |
| Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA. |
